Harborgen Biotechnologies, Inc.
About Harborgen Biotechnology company
Harborgen Biotechnology Company engaged in novel molecular biotechnology development with creative methodologies. Serve customer better than others is as our eternal pursuit.
The company's work mainly in three aspects: (1) scientific research: facing the international forefront of the development of biomedical science and technology, to carry out innovative research; (2) the industrial development: the development of advanced biomedical projects, excellent hatch achievements, promote industrialization of the results; (3) technical services: for the scientific institutes and universities of the world to provide advanced technology and technical support services.
At present the main focus of business is on DNA and related testing products development of precision medicine. The new bio- technologies has been developed by Harborgen including Gene Positioning System (GPS) in genome, qPCR Based Global Methylation System, One buffer one tube one step genomic DNA extraction, NGS Based DNA Differential Methylation (DDM), Unknown Origin Trace Amount DNA Amplification, Multiple function 2x PCR master mix etc.. Benefits of these Harborgen’s novel technologies allow scientists to explore the new scientific field, decreased cost, faster turnaround times for results, and easier procedures for user.
Harborgen is consisting of management, marketing, research and development, production and sales. Harborgen is the company to "professional, integrity, innovation, efficiency," to serve the purpose, to science and technology, quality of survival, to management efficiency for the business model, mutual benefit and win-win business strategy, and will continue put new and special products with high technology content, market potential to the market.